Journal of Signal Transduction Biophysical Research Communications, vol. 290, no. 1, pp. 47– 52, 2002. [51] A. Gordon, E. Hultman, L. Kaijser et al., “Creatine supple- mentation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance,” Cardiovascular Research, vol. 30, no. 3, pp. 413–418, 1995. [52] R. T. Matthews, R. J. Ferrante, P. Klivenyi et al., “Creatine and cyclocreatine attenuate MPTP neurotoxicity,” Experimental Neurology, vol. 157, no. 1, pp. 142–149, 1999. [53] L. Mazzini, C. Balzarini, R. Colombo et al., “Eﬀects of crea- tine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results,” Journal of the Neurological Sciences, vol. 191, no. 1-2, pp. 139– 144, 2001. [54] J. R. Stout, J. M. Eckerson, E. May, C. Coulter, and G. E. Bradley-Popovich, “Eﬀects of resistance exercise and creatine supplementation on myasthenia gravis: a case study,” Medicine and Science in Sports and Exercise, vol. 33, no. 6, pp. 869–872, 2001. [55] M. A. Tarnopolsky, D. J. Mahoney, J. Vajsar et al., “Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy,” Neurology, vol. 62, no. 10, pp. 1771–1777, 2004. [56] M. Vorgerd, T. Grehl, M. Ja¨ger et al., “Creatine therapy in myophosphorylase deﬁciency (McArdle disease): a placebo- controlled crossover trial,” Archives of Neurology, vol. 57, no. 7, pp. 956–963, 2000. [57] C. McGinley, A. Shafat, and A. E. Donnelly, “Does antioxi- dant vitamin supplementation protect against muscle dam- age?” Sports Medicine, vol. 39, no. 12, pp. 1011–1032, 2009. [58] K. Nakazato, E. Ochi, and T. Waga, “Dietary apple polyphe- nols have preventive eﬀects against lengthening contraction- induced muscle injuries,” Molecular Nutrition and Food Research, vol. 54, no. 3, pp. 364–372, 2010. [59] N. A. Strobel, J. M. Peake, A. Matsumoto, S. A. Marsh, J. S. Coombes, and G. D. Wadley, “Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis,” Medicine and Science in Sports and Exercise, vol. 43, no. 6, pp. 1017– 1024, 2010. [60] B. N. Ames, M. K. Shigenaga, and T. M. Hagen, “Oxidants, antioxidants, and the degenerative diseases of aging,” Pro- ceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915–7922, 1993. [61] B. P. Yu and H. Y. Chung, “Adaptive mechanisms to oxidative stress during aging,” Mechanisms of Ageing and Development, vol. 127, no. 5, pp. 436–443, 2006. [62] L. L. Ji, “Exercise at old age: does it increase or alleviate oxidative stress?” Annals of the New York Academy of Sciences, vol. 928, pp. 236–247, 2001. [63] A. McArdle, A. Vasilaki, and M. Jackson, “Exercise and skele- tal muscle ageing: cellular and molecular mechanisms,” Ageing Research Reviews, vol. 1, no. 1, pp. 79–93, 2002. [64] L. L. Ji, D. Dillon, and E. Wu, “Alteration of antioxidant enzymes with aging in rat skeletal muscle and liver,” American Journal of Physiology, vol. 258, no. 4, part 2, pp. R918–R923, 1990. [65] T. A. Luhtala, E. B. Roecker, T. Pugh, R. J. Feuers, and R. Weindruch, “Dietary restriction attenuates age-related increases in rat skeletal muscle antioxidant enzyme activi- ties,” Journals of Gerontology, vol. 49, no. 5, pp. B231–B238, 1994. [66] J. Hollander, J. Bejma, T. Ookawara, H. Ohno, and L. L. Ji, “Superoxide dismutase gene expression in skeletal 13 muscle: ﬁber-speciﬁc eﬀect of age,” Mechanisms of Ageing and Development, vol. 116, no. 1, pp. 33–45, 2000. [67] S. Oh-Ishi, K. Toshinai, T. Kizaki et al., “Eﬀects of aging and/or training on antioxidant enzyme system in diaphragm of mice,” Respiration Physiology, vol. 105, no. 3, pp. 195–202, 1996. [68] L. L. Ji, “Exercise-induced modulation of antioxidant defense,” Annals of the New York Academy of Sciences, vol. 959, pp. 82–92, 2002. [69] I. Irrcher, V. Ljubicic, and D. A. Hood, “Interactions between ROS and AMP kinase activity in the regulation of PGC-1α transcription in skeletal muscle cells,” American Journal of Physiology—Cell Physiology, vol. 296, no. 1, pp. C116–C123, 2009. [70] M. J. Jackson, “Skeletal muscle aging: role of reactive oxygen species,” Critical Care Medicine, vol. 37, no. 10, pp. S368– S371, 2009. [71] A. Musaro` , S. Fulle, and G. Fano` , “Oxidative stress and muscle homeostasis,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 3, pp. 236–242, 2010. [72] C. Mammucari and R. Rizzuto, “Signaling pathways in mitochondrial dysfunction and aging,” Mechanisms of Ageing and Development, vol. 131, no. 7-8, pp. 536–543, 2010. [73] E. Marzetti, J. C. Y. Hwang, H. A. Lees et al., “Mitochondrial death eﬀectors: relevance to sarcopenia and disuse muscle atrophy,” Biochimica et Biophysica Acta—General Subjects, vol. 1800, no. 3, pp. 235–244, 2010. [74] D. A. Hood, I. Irrcher, V. Ljubicic, and A. M. Joseph, “Coordination of metabolic plasticity in skeletal muscle,” Journal of Experimental Biology, vol. 209, part 12, pp. 2265– 2275, 2006. [75] S. C. Choi, D. E. Befroy, R. Codella et al., “Paradoxical eﬀects of increased expression of PGC-1α on muscle mito- chondrial function and insulin-stimulated muscle glucose metabolism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19926– 19931, 2008. [76] T. R. Koves, P. Li, J. An et al., “Peroxisome proliferator- activated receptor-γ co-activator 1α-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial ineﬃciency,” Journal of Biological Chemistry, vol. 280, no. 39, pp. 33588–33598, 2005. [77] H. Liang and W. F. Ward, “PGC-1α: a key regulator of energy metabolism,” American Journal of Physiology—Advances in Physiology Education, vol. 30, no. 4, pp. 145–151, 2006. [78] L. F. Michael, Z. Wu, R. B. Cheatham et al., “Restoration of insulin-sensitive glucose transporter (GLUT4) gene expres- sion in muscle cells by the transcriptional coactivator PGC- 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 3820–3825, 2001. [79] G. Uguccioni and D. A. Hood, “The importance of PGC- 1α in contractile activity-induced mitochondrial adapta- tions,” American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 2, pp. E361–E371, 2011. [80] D. P. Kelly and R. C. Scarpulla, “Transcriptional regulatory circuits controlling mitochondrial biogenesis and function,” Genes and Development, vol. 18, no. 4, pp. 357–368, 2004. [81] E. Barbieri, M. Battistelli, L. Casadei et al., “Morphofunc- tional and biochemical approaches for studying mitochon- drial changes during myoblasts diﬀerentiation,” Journal of Aging Research, vol. 2011, Article ID 845379, 16 pages, 2011. [82] H. Wu, S. B. Kanatous, F. A. Thurmond et al., “Regulation of mitochondrial biogenesis in skeletal muscle by caMK,” Science, vol. 296, no. 5566, pp. 349–352, 2002.